Clinical Trial Update: Cabazitaxel in Relapsed and Metastatic NSCLC [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports completion of a cabazitaxel study in relapsed and metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: NSCLC | Phase 2 | Status: COMPLETED